SterisSTEEarnings & Financial Report
Steris plc is an American-Irish-based medical equipment company specializing in sterilization and surgical products for the US healthcare system. Steris is operationally headquartered in Mentor, Ohio, and has been legally registered in Dublin, Ireland, for tax purposes since 2018. Previously the company was registered in the United Kingdom from 2014 to 2018.
Revenue
$1.3B
Gross Profit
$578.8M
Operating Profit
$219.7M
Net Profit
$150.0M
Gross Margin
43.6%
Operating Margin
16.5%
Net Margin
11.3%
YoY Growth
-1.0%
EPS
$1.51
Steris Q2 FY2025 Financial Summary
Steris reported revenue of $1.3B (down 1.0% YoY) for Q2 FY2025, with a net profit of $150.0M (up 30.1% YoY) (11.3% margin). Cost of goods sold was $750.1M, operating expenses totaled $359.1M.
Key Financial Metrics
| Total Revenue | $1.3B |
|---|---|
| Net Profit | $150.0M |
| Gross Margin | 43.6% |
| Operating Margin | 16.5% |
| Report Period | Q2 FY2025 |
Steris Annual Revenue by Year
Steris annual revenue history includes year-by-year totals (for example, 2025 revenue was $5.5B).
| Year | Annual Revenue |
|---|---|
| 2025 | $5.5B |
| 2024 | $5.1B |
| 2023 | $4.5B |
| 2022 | $4.2B |
Steris Quarterly Revenue & Net Profit History
Steris results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q3 FY2026 | $1.5B | +9.2% | $192.9M | 12.9% |
| Q2 FY2026 | $1.5B | +9.9% | $191.9M | 13.1% |
| Q1 FY2026 | $1.4B | +8.7% | $177.4M | 12.8% |
| Q4 FY2025 | $1.5B | +32.6% | $145.7M | 9.8% |
| Q3 FY2025 | $1.4B | -1.8% | $173.5M | 12.7% |
| Q2 FY2025 | $1.3B | -1.0% | $150.0M | 11.3% |
| Q1 FY2025 | $1.3B | -0.4% | $145.4M | 11.4% |
| Q4 FY2024 | $1.1B | -19.4% | $-1.4M | -0.1% |
Income Statement
| Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | Q3 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.12B | $1.28B | $1.33B | $1.37B | $1.48B | $1.39B | $1.46B | $1.50B |
| YoY Growth | -19.4% | -0.4% | -1.0% | -1.8% | 32.6% | 8.7% | 9.9% | 9.2% |
Balance Sheet
| Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | Q3 2026 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $11.06B | $10.11B | $10.24B | $10.01B | $10.15B | $10.40B | $10.41B | $10.59B |
| Liabilities | $4.75B | $3.74B | $3.63B | $3.58B | $3.53B | $3.44B | $3.39B | $3.42B |
| Equity | $6.30B | $6.35B | $6.59B | $6.42B | $6.60B | $6.96B | $7.01B | $7.15B |
Cash Flow
| Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | Q3 2026 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $254.8M | $303.7M | $250.7M | $332.8M | $260.8M | $420.0M | $287.8M | $298.2M |